Demo Sign up Log In

Vertex Pharmaceuticals (VRTX)

Financing Cash Flow

-$426.70M

Quarterly · Period ending: Jun 30, 2026 · USD

VRTX Financing Cash Flow

Latest reported-$426.70Mperiod endingJun 30, 2026

Latest reported-$426.70Mperiod endingJun 30, 2026

VRTX Quarterly Cash from Financing ($26.00M → -$426.70M)

Quarterly financing cash flow

High-resolution chart · PNG

VRTX financing cash flow history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Vertex Pharmaceuticals Financing Cash Flow — Quarterly (USD)
Period ending	Financing Cash Flow (USD)
Jun 30, 2001	2,680,000
Mar 31, 2001	7,591,000
Dec 31, 2000	10,598,000
Sep 30, 2000	345,490,000
Jun 30, 2000	9,884,000
Mar 31, 2000	178,059,000
Dec 31, 1999	900,000
Sep 30, 1999	900,000
Jun 30, 1999	400,000
Mar 31, 1999	600,000
Dec 31, 1998	100,000
Sep 30, 1998	1,500,000
Jun 30, 1998	1,300,000
Mar 31, 1998	1,300,000
Dec 31, 1997	1,600,000
Sep 30, 1997	1,100,000
Jun 30, 1997	12,000,000
Mar 31, 1997	150,100,000
Dec 31, 1996	2,600,000
Sep 30, 1996	78,100,000
Jun 30, 1996	6,000,000
Mar 31, 1996	400,000
Dec 31, 1995	700,000
Sep 30, 1995	100,000
Jun 30, 1995	600,000
Mar 31, 1995	400,000
Dec 31, 1994	14,900,000
Sep 30, 1994	-300,000
Jun 30, 1994	-200,000
Mar 31, 1994	57,500,000
Dec 31, 1993	-400,000
Sep 30, 1993	-500,000
Jun 30, 1993	2,900,000
Mar 31, 1993	-400,000
Dec 31, 1992	-300,000
Sep 30, 1992	-300,000
Jun 30, 1992	-300,000
Mar 31, 1992	-300,000
Dec 31, 1991	25,300,000
Sep 30, 1991	26,000,000

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.